Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease.
METHODS
Adrenal cortex autoantibodies (ACA), steroid-producing cell autoantibodies (StCA) and autoantibodies (Abs) to steroidogenic enzymes in three groups of patients with premature ovarian failure (POF), 15 with autoimmune Addison's disease (AD), 26 with non-adrenal autoimmune diseases and 31 with isolated POF, have been assessed.


METHODS
ACA and StCA were measured using an immunofluorescence technique. Abs to 21-hydroxylase (21-OH), to 17alpha-hydroxylase (17alpha-OH) and to cytochrome P450 side-chain cleavage (P450scc) were measured using an immunoprecipitation assay.


RESULTS
Seventy-three percent of patients with POF and AD were positive for StCA, 93% for 17alpha-OH and/or P450scc Abs, 93% for ACA and 100% for 21-OH Abs. Among patients with POF and non-adrenal autoimmune diseases, 8% were positive for StCA, 12% for 17alpha-OH and/or P450scc Abs, and 8% and 12% for ACA and 21-OH Abs respectively. StCA, 17alpha-OH and/or P450scc Abs were all found in 10% of patients with isolated POF, and 13% had ACA and 21-OH Abs. All StCA-, 17alpha-OH- and/or P450scc Abs-positive patients were also positive for ACA and 21-OH Abs. Two patients with isolated POF who were ACA and 21-OH Ab positive developed AD 3 and 5 Years after the onset of POF.


CONCLUSIONS
This study has shown that, when POF is associated with AD, StCA, 17alpha-OH and/or P450scc Abs are present in the majority of patients, while in the other two groups these Abs are detectable in a much lower proportion of patients. Measurement of ACA/21-OH Abs in some patients with POF may be important in identifying patients at risk of developing overt AD.
Chair of Clinical Immunology and Allergy, Division of Endocrinology, Department of Medical and Surgical Sciences, University of Padua, Via Ospedale 105, Padua, Italy.
C
C
Dal Pra
S
S
Chen
J
J
Furmaniak
B Rees
BR
Smith
B
B
Pedini
A
A
Moscon
R
R
Zanchetta
C
C
Betterle
D000224:Addison Disease / Q000150:complications / Q000276:immunology*; D000302:Adrenal Cortex / Q000276:immunology; D000328:Adult; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000276:immunology; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000276:immunology; D004798:Enzymes / Q000276:immunology* / Q000378:metabolism*; D005260:Female; D006801:Humans; D016649:Primary Ovarian Insufficiency / Q000150:complications / Q000276:immunology*; D013254:Steroid 17-alpha-Hydroxylase / Q000276:immunology; D013256:Steroids / Q000096:biosynthesis*
D001323:Autoantibodies; D004798:Enzymes; D013256:Steroids; D013254:Steroid 17-alpha-Hydroxylase; D002786:Cholesterol Side-Chain Cleavage Enzyme